Browse the evidence

Endogenous ghrelin is physiologically relevant for regulating lipid-metabolizing enzymes in white adipose tissue, as ghrelin-deficient mice exhibit decreased expression of fat-storage enzymes (LPL, SCD1).

Your body's natural ghrelin production helps regulate how fat cells store fat. Without it, fat-storage enzymes are less active, which may protect against obesity on high-fat diets.

In aged muscle, mTORC1 is hyperphosphorylated but fails to induce protein synthesis effectively, leading to anabolic resistance and contributing to sarcopenia.

As you age, your muscles become 'anabolically resistant,' meaning standard training might not trigger muscle growth as efficiently. Your mTOR pathway may be 'stuck' in a state that doesn't effectively build protein. To counter this, older adults may need to focus on high-intensity resistance training and adequate protein intake to overcome this resistance and maintain muscle mass.

Histidine supplementation is inappropriate for patients with liver disease due to the risk of hepatic enlargement and increased blood ammonia and glutamine levels.

If you have liver disease, do not take histidine supplements. The paper indicates this can cause your liver to enlarge and increase toxic ammonia levels in your blood. Stick to dietary sources unless advised otherwise by your doctor.

In non-insulin-dependent diabetes mellitus (NIDDM), skeletal muscle exhibits impaired free fatty acid (FFA) utilization and oxidation during both fasting and postprandial states, characterized by reduced fractional extraction and uptake of oleate in the fasting state and a failure to suppress FFA uptake after meal ingestion.

If you have type 2 diabetes, your muscles are less efficient at burning fat for energy, especially when you haven't eaten, and they fail to slow down fat uptake after you eat. This isn't because your muscle structure is broken, but because high blood sugar and insulin resistance are forcing your body to burn more glucose and store more fat. Managing blood glucose levels is critical to restoring normal fat oxidation.

Myostatin inhibition is a potential therapeutic target for muscle atrophy, but current clinical trials have largely failed to increase muscle strength in patients.

Do not expect myostatin-inhibiting supplements or drugs to build muscle strength currently. Clinical trials have failed to show benefits. Focus on resistance training, which naturally modulates these pathways effectively.

Sirtuin levels decrease with age in various tissues, and this decrease is associated with increased DNA damage, oxidative stress, and frailty.

Sirtuin levels naturally decline with age, contributing to frailty and DNA damage. However, lifestyle interventions like calorie restriction and exercise can help maintain or increase sirtuin levels, supporting healthspan.

Maintaining elevated free fatty acid (FFA) levels during hyperinsulinemia significantly inhibits skeletal muscle glucose storage (glycogen synthesis) and reduces glycogen synthase fractional velocity, representing the primary mechanism of FFA-induced insulin resistance in muscle.

When your insulin is high (e.g., after a high-carb meal), your body's ability to store glucose as glycogen in muscles is significantly reduced if free fatty acids are also circulating. To maximize muscle glycogen storage, minimize fat intake in meals containing carbohydrates, or separate high-fat and high-carb meals to allow distinct metabolic phases.

Gut microbiota promotes diet-induced obesity and hepatic steatosis through Farnesoid X Receptor (FXR) signaling; FXR deficiency or inhibition alters bile acid profiles to suppress this pathway, resulting in reduced adiposity and improved glucose metabolism.

Your gut bacteria play an active role in how your body processes fat and stores energy, specifically through a receptor called FXR. While this research is in mice, it suggests that maintaining a diverse microbiota and avoiding factors that disrupt bile acid signaling (like excessive antibiotic use or specific dietary patterns that alter bile acids) may support metabolic health. Focus on whole foods that support microbial diversity rather than just calorie counting.

Serum leptin levels are significantly higher in women than in men for any given measure of obesity (BMI or percent body fat) above 25% body fat, indicating a state of relative leptin resistance in women.

If you are a woman, your body naturally produces more leptin than a man of the same weight or body fat percentage. This higher baseline may contribute to a state of 'leptin resistance,' making it physiologically harder to sustain diet-induced weight loss compared to men. This is a biological difference, not a failure of willpower.

In men, but not women, serum leptin levels are negatively correlated with insulin sensitivity (maximal glucose uptake) and positively correlated with blood pressure and waist-to-hip ratio.

For men, higher leptin levels are a marker of insulin resistance and higher blood pressure. For women, leptin levels are primarily driven by total body fat percentage and do not strongly predict insulin resistance or blood pressure in the same way. This suggests different metabolic risks associated with high leptin in each gender.

Adipose tissue insulin resistance (Adipo-IR) is a primary driver of metabolic and histological abnormalities in obese patients with NAFLD, with worsening Adipo-IR correlating with increased liver fibrosis and hepatic insulin resistance.

For obese individuals with fatty liver, simply having a high BMI is not the only risk factor; the metabolic health of the fat tissue matters significantly. If your fat tissue is insulin resistant, it releases fatty acids that damage the liver. Interventions that improve adipose tissue insulin sensitivity (like weight loss or specific medications like thiazolidinediones) may help reduce liver fibrosis and metabolic risk.

In human skeletal muscle, insulin resistance is caused by a defect in GLUT4 trafficking and translocation, leading to the accumulation of GLUT4 in dense intracellular membrane vesicles rather than its recruitment to the cell surface.

For individuals with insulin resistance, simply having normal levels of glucose transporters (GLUT4) in their muscles is not enough. The problem lies in the cellular machinery's ability to move these transporters to the cell surface in response to insulin. This suggests that interventions must focus on improving cellular signaling and trafficking efficiency, not just increasing transporter abundance.

Short-term satiety signals (like CCK and glucose) are insufficient to regulate long-term body adiposity and can be overridden by long-term regulators (insulin and leptin).

Feeling full from a meal doesn't guarantee you won't gain weight long-term. Your body uses long-term hormones like leptin and insulin to set your 'weight thermostat.' If your diet disrupts these hormones, you might feel full but still gain weight because your brain isn't getting the long-term signal that you have enough energy stores.

In adolescent girls with PCOS, hyperandrogenemia (specifically elevated bioavailable testosterone) is an independent risk factor for metabolic syndrome, increasing the odds of MBS by approximately 4-fold per quartile of testosterone after adjusting for obesity and insulin resistance.

For adolescent girls with PCOS, high testosterone levels are a direct driver of metabolic syndrome risk, separate from how much they weigh. This means that even if a patient is not obese, high androgens can still put them at risk for metabolic issues. Treatment strategies should consider targeting androgen levels, not just weight.

Chronic nutrient excess and obesity overwhelm adipose tissue storage capacity, causing ectopic lipid accumulation in liver and muscle, which triggers lipotoxicity and metaflammation, leading to insulin resistance and metabolic disease.

When you consistently consume more energy than your body can store in fat tissue, the excess fat spills over into organs like the liver and muscles. This spillage is toxic and triggers inflammation that blocks insulin, leading to type 2 diabetes. Managing nutrient intake to stay within your body's storage capacity is key to preventing this cascade.

Saturated fatty acids (e.g., palmitate) and oxidized cholesterol drive metaflammation by activating stress kinases (JNK, PKC, PKR) and inflammatory pathways (TLR4, NF-kB), which directly inhibit insulin signaling.

High intake of saturated fats and oxidized lipids can directly interfere with how your cells respond to insulin by triggering inflammatory stress signals. Reducing these specific lipid types may help maintain insulin sensitivity.

Obesity causes hypertension through multiple mechanisms including sympathetic nervous system activation, renin-angiotensin system (RAS) overexpression in adipose tissue, and renal sodium retention.

If you have obesity, your risk for high blood pressure is significantly increased due to biological mechanisms involving your nervous system and hormones. Managing your weight through diet and exercise can help mitigate these risks.

Obese individuals have attenuated postprandial secretion of satiation signals like PYY and GLP-1 compared to lean individuals, which may contribute to obesity.

If you are obese, your body may naturally produce less of the 'fullness' hormones (like PYY) after eating compared to lean people. This is a biological factor, not just a lack of willpower.

In healthy elderly individuals, the combination of amino acids and glucose-induced hyperinsulinemia fails to stimulate muscle protein synthesis, resulting in a blunted anabolic response compared to young adults.

For older adults, consuming protein alongside carbohydrates (like in typical mixed meals or standard supplements) may not build muscle because the insulin response blocks the muscle-building signal. To potentially maximize muscle protein synthesis, older adults might benefit from consuming amino acids or protein without concurrent carbohydrate intake, as the addition of glucose appears to blunt the anabolic response in aging muscle.

Insulin resistance and compensatory hyperinsulinemia drive hyperandrogenemia in PCOS by disrupting the hypothalamus-hypophysis-ovary axis and directly stimulating ovarian steroidogenesis, creating a self-perpetuating vicious cycle.

For women with PCOS, managing insulin resistance is likely more critical for symptom control than focusing solely on reproductive aspects. Strategies that improve insulin sensitivity (such as dietary changes or specific medications like metformin, though not detailed here) may help reduce androgen levels and improve ovarian function.

Central insulin resistance is a common pathophysiological mechanism linking Type 2 Diabetes and Alzheimer's Disease, contributing to cognitive decline and metabolic dysregulation.

If you have Type 2 Diabetes, managing your blood sugar is also about protecting your brain. Central insulin resistance is a key link between diabetes and cognitive decline (like Alzheimer's). Prioritizing insulin sensitivity through lifestyle or medication may help preserve cognitive function, as the brain relies on proper insulin signaling for memory and metabolic health.

Insulin crosses the blood-brain barrier via a saturable transport system, and this transport is impaired in conditions like obesity, diabetes, and aging.

High peripheral insulin levels (common in obesity and diabetes) may not effectively reach the brain due to a saturated transport system. This 'central insulin resistance' can occur even if peripheral insulin is high, potentially contributing to metabolic and cognitive issues.

Insulin in the brain acts as an anorexigenic hormone, regulating food intake and energy expenditure through hypothalamic receptors, distinct from its peripheral anabolic effects.

Insulin in the brain helps regulate hunger. Disruptions in this central signaling (central insulin resistance) may contribute to overeating and obesity. Restoring healthy insulin signaling in the brain could theoretically support better appetite regulation.

Continuous positive airway pressure (CPAP) therapy effectively reverses sleep-related disordered breathing and daytime symptoms, and mitigates acute pathophysiologic responses such as sympathetic activation and endothelin elevation, though long-term cardiovascular mortality benefits remain unproven.

If you have been diagnosed with Obstructive Sleep Apnea, CPAP is the most effective treatment to stop breathing interruptions and reduce daytime sleepiness. While it may not yet be proven to extend life expectancy in heart failure patients, it significantly improves cardiovascular markers like blood pressure and sympathetic activity. If you struggle with the mask, ask your provider about heated humidification or nasal sprays to improve comfort and adherence.